v3.26.1
Statements of Cash Flows - USD ($)
$ in Thousands
12 Months Ended
Mar. 31, 2026
Mar. 31, 2025
Cash Flows from Operating Activities:    
Net loss $ (16,715) $ (11,410)
Adjustments to reconcile net loss to net cash used in operating activities:    
Stock-based compensation 529 1,628
Stock option cancellations 3,732 0
Issuance of common stock for equity line of credit commitment fee 267 0
Depreciation and amortization expense 12 183
Issuance of common stock, net of discount for lack of marketability 0 101
Changes in operating assets - (increase)/decrease:    
Other current assets (104) 310
Changes in operating liabilities - increase/(decrease):    
Accounts payable 24 184
Accrued expenses (27) 746
Net cash used in operating activities (12,282) (8,258)
Cash Flows from Investing Activities:    
Purchase of property and equipment (10) (14)
Net cash used in investing activities (10) (14)
Cash Flows from Financing Activities (increase/decrease):    
Gross proceeds from issuance of common stock 3,531 0
Direct financing costs for issuance of common stock (141) 0
Gross proceeds from warrant inducement 2,546 0
Direct transaction costs for warrant inducement (291) 0
Gross proceeds from issuance and exercises of pre-funded warrants 5,000 0
Direct financing costs for issuance of pre-funded warrants (485) 0
Gross proceeds from issuance of common stock, pre-funded and common warrants 0 10,025
Direct transaction costs for issuance of common stock, pre-funded and common warrants 0 (1,052)
Payment of issuance costs for registration statement 0 (176)
Gross proceeds from exercise of warrants 0 1
Proceeds from sales of common stock 0 2
Net cash provided by financing activities 10,160 8,800
Net change in cash and cash equivalents (2,132) 528
Cash and cash equivalents, at beginning of period 9,136 8,608
Cash and cash equivalents, at end of period 7,004 9,136
Non-cash financing activities:    
Recognition of deferred financing costs associated with issuance of common stock (176) 0
Proceeds from cashless exercise of warrants 1 39
Warrants issued for equity issuance costs 0 479
Issuance of Common Stock for Extinguishment of Convertible Debt [Member]    
Non-cash financing activities:    
Convertible notes converted into common stock 0 1,330
Settlement/conversion to common shares for debt issuance costs $ 0 $ (153)